The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system.
Mandl, KD; Glauser, T; Krantz, ID; Avillach, P; Bartels, A; Beggs, AH; Biswas, S; Bourgeois, FT; Corsmo, J; Dauber, A; et al.
Genetics in Medicine.
2020;
22:371-380.
Elucidating the beneficial role of ppar agonists in cardiac diseases.
Khuchua, Z; Glukhov, AI; Strauss, AW; Javadov, S.
International Journal of Molecular Sciences.
2018;
19:3464-3464.
The effects of PPAR stimulation on cardiac metabolic pathways in barth syndrome mice.
Schafer, C; Moore, V; Dasgupta, N; Javadov, S; James, JF; Glukhov, AI; Strauss, AW; Khuchua, Z.
Frontiers in Pharmacology.
2018;
9.
The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome.
Huang, Y; Powers, C; Moore, V; Schafer, C; Ren, M; Phoon, CK L; James, JF; Glukhov, AV; Javadov, S; Vaz, FM; et al.
Orphanet Journal of Rare Diseases.
2017;
12:49-9.
Evaluation of Fellows' CrossTalk Effectiveness in Promoting Transdisciplinary Networking and Research.
Wikenheiser-Brokamp, KA; Klein, M; Hershey, GK K; Devarajan, P; DeWitt, TG; Loch, J; Strauss, AW; Muglia, LJ; Hostetter, MK.
The Journal of Pediatrics.
2017;
181:5-6.e3.
Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy.
Sleeper, LA; Towbin, JA; Colan, SD; Hsu, D; Orav, EJ; Lemler, MS; Clunie, S; Messere, J; Fountain, D; Miller, TL; et al.
The Journal of Pediatrics.
2016;
170:173-80.e1-4-180.e4.